List of Session for which you can submit abstracts
Core Symposia
Title | Chairperson | ||
---|---|---|---|
1 | Single cell biology of human cancer | Hiroyuki Aburatani Shumpei Ishikawa |
The University of Tokyo The University of Tokyo |
2 | Precision disease modeling: organoid-driven cancer research | Toshiro Sato Hiroshi Seno |
Keio University Kyoto University |
International Sessions
Title | Chaiperson | ||
---|---|---|---|
1 | Extracellular vesicle-mediated cross-talk in cancer | Takahiro Ochiya Tang-Long Shen |
Tokyo Medical University National Taiwan University |
2 | Cell death, tumor suppressors and beyond | Chiaki Takahashi Sharad Kumar |
Kanazawa University University of South Australia |
3 | Epitranscriptome and tumor Heterogeneity | Hideshi Ishii Hao-Jian Zhang |
Osaka University Wuhan University |
4 | Targeting super-enhancers in intractable cancer | Miwa Tanaka H. Phillip Koeffler |
The Cancer Inst., JFCR National University of Singapore |
5 | Advances in cellular immunotherapy | Naoki Hosen Chenqi Xu |
Osaka University Chinese Academy of Sciences |
6 | Epigenomic rewiring for oncogenic signal activation | Atsushi Kaneda Patrick Tan |
Chiba University Duke-NUS Medical School |
7 | Potentials of simulation modelling research in cancer control | Kota Katanoda Eleonora Feletto |
National Cancer Center Cancer Council New South Wales |
8 | Theoretic strategy for immune checkpoint inhibitor-based combination therapy | Kenji Chamoto Mien-Chie Hung |
Kyoto University China Medical University |
9 | Super-acceleration of early drug development | Ken-ichiro Kamei Lijian Hui |
Kyoto University Institute for Advanced Study Chinese Academy of Sciences |
10 | Single-cell analysis in cancer research | Shinichi Yachida Woong-Yang Park |
Osaka University Sungkyunkwan University |
11 | Frontline of genomic research in cancer | Keisuke Kataoka Hongbin Shen |
Keio University Nanjing Medical University |
Symposia
Title | Chairperson | ||
---|---|---|---|
1 | Forefront research on chromatin dynamics and its application to cancer medicine | Hiroyuki Seimiya Makoto Nakanishi |
Japanese Foundation For Cancer Research The University of Tokyo |
2 | Metastasis: development of novel strategies through multifaceted understanding | Kyoko Hida Daizo Koinuma |
Hokkaido University The University of Tokyo |
3 | Development of cancer immunotherapy for precision medicine | Hiroyoshi Nishikawa Kazuma Kiyotani |
National Cancer Center Japanese Foundation For Cancer Research |
4 | Evolving molecular targeted therapy | Seiji Yano Ryohei Katayama |
Kanazawa University Japanese Foundation for Cancer Research |
5 | Aging with and without cancer | Eiji Hara Hozumi Motohashi |
Osaka University Tohoku University |
6 | Cancer metabolism: beyond the Warburg | Atsushi Hirao Tomoyoshi Soga |
Kanazawa University Keio University |
7 | Futuristic methods for precision cancer medicine | Hiroshi Nishihara Issei Imoto |
Keio University Aichi Cancer Center Hospital |
8 | Understanding and targeting genetically-complex human malignancies | Masaki Mori Fumihiko Ishikawa |
Kyushu University RIKEN |
9 | Phenotypic heterogeneity and plasticity in cancer regulated by epigenetic mechanisms | Issay Kitabayashi Mitsuyoshi Nakao |
National Cancer Center Research Institute Kumamoto University |
10 | Evolution of pathology: from morphological diagnosis towards a universal research platform | Yae Kanai Kengo Takeuchi |
Keio University Japanese Foundation for Cancer Research |
11 | Genomic analysis toward future clinical application | Johji Inazawa Katsutoshi Oda |
Tokyo Medical and Dental University The University of Tokyo |
12 | Microbiota and cancer | Kenya Honda Naoko Ohtani |
Keio University Osaka City University |
13 | Cutting-edge animal models for cancer research | Yasuhiro Yamada Masato Kanemaki |
The University of Tokyo National Institute of Genetics |
14 | Elucidating how chromosomal instability arises to identify cancer therapy targets | Kozo Tanaka Ryu-Suke Nozawa |
Tohoku University Japanese Foundation For Cancer Research |
15日本語 | Issues and future directions of academia-pharma collaborations for novel drug development | Naoya Fujita Noriko Gotoh |
Japanese Foundation for Research Institute Kanazawa University |
16 | Big data in cancer research | Seiya Imoto Hiroaki Miyata |
The University of Tokyo Keio University |
17 | Novel functions and clinical application of the most famous tumor suppressor gene p53 | Rieko Ohki Tomoaki Tanaka |
National Cancer Center Research Institute Chiba University |
18 | Latest evidence and perspective on liquid biopsy | Takayuki Yoshino Koji Ueda |
National Cancer Center Hospital East Japanese Foundation for Cancer Research |
19 | New horizons in tumor microenvironment regulation targeting inflammation and angiogenesis | Tetsuro Watabe Masanobu Oshima |
Tokyo Medical and Dental University Kanazawa University |
20 | Drug discovery and diagnosis enhanced with AI | Satoru Miyano Masahiro Jinzaki |
Tokyo Medical and Dental University Keio University |
21 | Next-generation imaging tools pioneered by light | Shinae Kizaka-Kondoh Mako Kamiya |
Tokyo Institute of Technology The University of Tokyo |
22 | Relationship between clonal hematopoiesis and hematological malignancies/cardiovascular diseases/solid tumors | Toshio Kitamura Atsushi Iwama |
The University of Tokyo The University of Tokyo |